ArticleFrontiers in medicine2026
Early risk stratification of sepsis-related liver injury via machine learning: a multicohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis-related liver injury (SRLI) is associated with poor prognosis and high morbidity in septic patients. Early mitigation of liver injury is crucial for improving outcomes in the critically ill. However, early detection and intervention remain challenging, due in part to the lack of effective diagnostic and screening strategies. This study aimed to apply machine learning (ML) approaches to identify significant predictors for the onset of SRLI, with the goal of facilitating early identification of high-risk patients. Methods: This retrospective study utilized data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, divided into training and internal validation cohorts. An additional external validation cohort consisted of 120 sepsis patients from Nanjing Jinling Hospital. We constructed seven ML models and two conventional assessment scales to predict the risk of SRLI in patients who did not meet the SRLI criteria within the first 24 h of ICU admission. The Boruta algorithm was employed for feature selection. Hyperparameter tuning was performed on the training set using grid search. Model performance was evaluated by the area under the receiver operating characteristic curve (ROC-AUC) and precision-recall area under the curve (PR-AUC), along with specificity, sensitivity, accuracy, F1 score. The clinical utility of the models was evaluated using decision curve analysis. Shapley additive explanation (SHAP) was used to provide clinicians with an intuitive understanding of the machine learning model. Results: After applying exclusion criteria, 9,434 sepsis patients from MIMIC-IV were included for model development. The Random Forest (RF) model demonstrated superior overall predictive performance in internal validation, achieving an area under the curve of 0.867, precision-recall area under the curve of 0.392. Decision curve analysis indicated the RF model provided a positive net benefit across a wide range of high risk thresholds. In the RF model, total bilirubin, international normalized ratio, sequential organ failure assessment, logistic organ dysfunction system, and prothrombin time were the most important indexes during the initial 24 hours following ICU admission, according to SHAP value. In the external validation, the RF model also outperformed all others (ROC-AUC: 0.862, PR-AUC: 0.735). Conclusion: Our study explored ML-based models for predicting SRLI among sepsis at an earlier stage and the performance of random forest model ranked best. The significant predictive contribution of prothrombin time highlights its potential as a key monitoring marker for early risk stratification in septic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.